Global Markets Direct’s, ‘Dilated Cardiomyopathy Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Dilated Cardiomyopathy, complete with latest updates, and special features on late-stage and discontinued projects. […]
December 2013 Life Science Industry Research Reports
Degenerative Disc Disease – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Degenerative Disc Disease Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Degenerative Disc Disease, complete with latest updates, and special features on late-stage and […]
Blood Coagulation – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Blood Coagulation Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Blood Coagulation, complete with latest updates, and special features on late-stage and discontinued projects. […]
Rhinovirus Infection – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Rhinovirus Infection Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Rhinovirus Infection, complete with latest updates, and special features on late-stage and discontinued projects. […]
Pompe Disease – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Pompe Disease Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Pompe Disease, complete with latest updates, and special features on late-stage and discontinued projects. […]
Plague – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Plague Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Plague, complete with latest updates, and special features on late-stage and discontinued projects. It also […]
Neuromyelitis Optica (Devic’s Syndrome) – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Neuromyelitis Optica (Devic’s Syndrome) Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Neuromyelitis Optica (Devic’s Syndrome), complete with latest updates, and special features on […]
Cedar Pollen Allergy – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Cedar Pollen Allergy Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cedar Pollen Allergy, complete with latest updates, and special features on late-stage and […]
Bacterial Conjunctivitis – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Bacterial Conjunctivitis Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Bacterial Conjunctivitis, complete with latest updates, and special features on late-stage and discontinued projects. […]
Rhabdomyosarcoma – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Rhabdomyosarcoma Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Rhabdomyosarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also […]
Stay In Touch